nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—CYP2C8—Etoposide—muscle cancer	0.0986	0.258	CbGbCtD
Fosphenytoin—CYP2B6—Doxorubicin—muscle cancer	0.0888	0.232	CbGbCtD
Fosphenytoin—ALB—Methotrexate—muscle cancer	0.0843	0.22	CbGbCtD
Fosphenytoin—CYP3A4—Vincristine—muscle cancer	0.0436	0.114	CbGbCtD
Fosphenytoin—CYP3A4—Etoposide—muscle cancer	0.04	0.105	CbGbCtD
Fosphenytoin—CYP3A4—Doxorubicin—muscle cancer	0.0273	0.0713	CbGbCtD
Fosphenytoin—Coma—Methotrexate—muscle cancer	0.00173	0.00279	CcSEcCtD
Fosphenytoin—Malaise—Dactinomycin—muscle cancer	0.00172	0.00278	CcSEcCtD
Fosphenytoin—Ecchymosis—Methotrexate—muscle cancer	0.00171	0.00276	CcSEcCtD
Fosphenytoin—Urine output increased—Methotrexate—muscle cancer	0.00171	0.00276	CcSEcCtD
Fosphenytoin—Leukopenia—Dactinomycin—muscle cancer	0.0017	0.00276	CcSEcCtD
Fosphenytoin—Coordination abnormal—Doxorubicin—muscle cancer	0.00166	0.0027	CcSEcCtD
Fosphenytoin—Back pain—Vincristine—muscle cancer	0.00165	0.00266	CcSEcCtD
Fosphenytoin—Sepsis—Methotrexate—muscle cancer	0.00164	0.00265	CcSEcCtD
Fosphenytoin—Vaginal inflammation—Doxorubicin—muscle cancer	0.00163	0.00265	CcSEcCtD
Fosphenytoin—Pulmonary embolism—Doxorubicin—muscle cancer	0.00163	0.00265	CcSEcCtD
Fosphenytoin—Injection site reaction—Doxorubicin—muscle cancer	0.00163	0.00263	CcSEcCtD
Fosphenytoin—Myalgia—Dactinomycin—muscle cancer	0.00162	0.00263	CcSEcCtD
Fosphenytoin—Dermatitis contact—Doxorubicin—muscle cancer	0.00162	0.00262	CcSEcCtD
Fosphenytoin—Lymphadenopathy—Methotrexate—muscle cancer	0.00161	0.0026	CcSEcCtD
Fosphenytoin—Hyperkalaemia—Doxorubicin—muscle cancer	0.00161	0.0026	CcSEcCtD
Fosphenytoin—Discomfort—Dactinomycin—muscle cancer	0.0016	0.00259	CcSEcCtD
Fosphenytoin—Salivary hypersecretion—Doxorubicin—muscle cancer	0.00159	0.00257	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Methotrexate—muscle cancer	0.00158	0.00256	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Etoposide—muscle cancer	0.00157	0.00255	CcSEcCtD
Fosphenytoin—Anaemia—Vincristine—muscle cancer	0.00157	0.00255	CcSEcCtD
Fosphenytoin—Agitation—Vincristine—muscle cancer	0.00156	0.00253	CcSEcCtD
Fosphenytoin—Polyuria—Methotrexate—muscle cancer	0.00156	0.00253	CcSEcCtD
Fosphenytoin—Fluid retention—Doxorubicin—muscle cancer	0.00155	0.00251	CcSEcCtD
Fosphenytoin—Infection—Dactinomycin—muscle cancer	0.00154	0.0025	CcSEcCtD
Fosphenytoin—Vaginal infection—Doxorubicin—muscle cancer	0.00154	0.0025	CcSEcCtD
Fosphenytoin—Vertigo—Vincristine—muscle cancer	0.00153	0.00248	CcSEcCtD
Fosphenytoin—Leukopenia—Vincristine—muscle cancer	0.00152	0.00247	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Dactinomycin—muscle cancer	0.00152	0.00246	CcSEcCtD
Fosphenytoin—Cramps of lower extremities—Doxorubicin—muscle cancer	0.0015	0.00243	CcSEcCtD
Fosphenytoin—Coma—Doxorubicin—muscle cancer	0.00149	0.00242	CcSEcCtD
Fosphenytoin—Rash maculo-papular—Doxorubicin—muscle cancer	0.00149	0.00241	CcSEcCtD
Fosphenytoin—Anorexia—Dactinomycin—muscle cancer	0.00148	0.0024	CcSEcCtD
Fosphenytoin—Ecchymosis—Doxorubicin—muscle cancer	0.00148	0.00239	CcSEcCtD
Fosphenytoin—Convulsion—Vincristine—muscle cancer	0.00147	0.00239	CcSEcCtD
Fosphenytoin—Hypertension—Vincristine—muscle cancer	0.00147	0.00238	CcSEcCtD
Fosphenytoin—Myalgia—Vincristine—muscle cancer	0.00145	0.00235	CcSEcCtD
Fosphenytoin—Chills—Etoposide—muscle cancer	0.00142	0.0023	CcSEcCtD
Fosphenytoin—Mental disability—Doxorubicin—muscle cancer	0.00142	0.0023	CcSEcCtD
Fosphenytoin—Sepsis—Doxorubicin—muscle cancer	0.00142	0.0023	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00142	0.00229	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00142	0.00229	CcSEcCtD
Fosphenytoin—Lymphadenopathy—Doxorubicin—muscle cancer	0.00139	0.00225	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Vincristine—muscle cancer	0.00139	0.00225	CcSEcCtD
Fosphenytoin—Infection—Vincristine—muscle cancer	0.00138	0.00223	CcSEcCtD
Fosphenytoin—Thrombophlebitis—Doxorubicin—muscle cancer	0.00137	0.00222	CcSEcCtD
Fosphenytoin—Osteoarthritis—Methotrexate—muscle cancer	0.00137	0.00222	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Vincristine—muscle cancer	0.00136	0.0022	CcSEcCtD
Fosphenytoin—Decreased appetite—Dactinomycin—muscle cancer	0.00135	0.00219	CcSEcCtD
Fosphenytoin—Dysgeusia—Etoposide—muscle cancer	0.00135	0.00219	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Vincristine—muscle cancer	0.00134	0.00217	CcSEcCtD
Fosphenytoin—Back pain—Etoposide—muscle cancer	0.00133	0.00216	CcSEcCtD
Fosphenytoin—Muscle spasms—Etoposide—muscle cancer	0.00132	0.00215	CcSEcCtD
Fosphenytoin—Anorexia—Vincristine—muscle cancer	0.00132	0.00214	CcSEcCtD
Fosphenytoin—Eye pain—Doxorubicin—muscle cancer	0.00131	0.00213	CcSEcCtD
Fosphenytoin—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00131	0.00212	CcSEcCtD
Fosphenytoin—Mood swings—Methotrexate—muscle cancer	0.0013	0.0021	CcSEcCtD
Fosphenytoin—Hypotension—Vincristine—muscle cancer	0.0013	0.0021	CcSEcCtD
Fosphenytoin—Ataxia—Methotrexate—muscle cancer	0.00129	0.00209	CcSEcCtD
Fosphenytoin—Feeling abnormal—Dactinomycin—muscle cancer	0.00128	0.00207	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Etoposide—muscle cancer	0.00128	0.00207	CcSEcCtD
Fosphenytoin—Anaemia—Etoposide—muscle cancer	0.00127	0.00206	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Methotrexate—muscle cancer	0.00127	0.00205	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00126	0.00205	CcSEcCtD
Fosphenytoin—Insomnia—Vincristine—muscle cancer	0.00126	0.00203	CcSEcCtD
Fosphenytoin—Paraesthesia—Vincristine—muscle cancer	0.00125	0.00202	CcSEcCtD
Fosphenytoin—Malaise—Etoposide—muscle cancer	0.00124	0.00201	CcSEcCtD
Fosphenytoin—Vertigo—Etoposide—muscle cancer	0.00124	0.00201	CcSEcCtD
Fosphenytoin—Leukopenia—Etoposide—muscle cancer	0.00123	0.002	CcSEcCtD
Fosphenytoin—Body temperature increased—Dactinomycin—muscle cancer	0.00123	0.00199	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00123	0.00199	CcSEcCtD
Fosphenytoin—Loss of consciousness—Etoposide—muscle cancer	0.00121	0.00196	CcSEcCtD
Fosphenytoin—Decreased appetite—Vincristine—muscle cancer	0.00121	0.00195	CcSEcCtD
Fosphenytoin—Cough—Etoposide—muscle cancer	0.0012	0.00195	CcSEcCtD
Fosphenytoin—Convulsion—Etoposide—muscle cancer	0.00119	0.00193	CcSEcCtD
Fosphenytoin—Hypertension—Etoposide—muscle cancer	0.00119	0.00193	CcSEcCtD
Fosphenytoin—Constipation—Vincristine—muscle cancer	0.00119	0.00192	CcSEcCtD
Fosphenytoin—Osteoarthritis—Doxorubicin—muscle cancer	0.00119	0.00192	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00119	0.00192	CcSEcCtD
Fosphenytoin—Diplopia—Doxorubicin—muscle cancer	0.00119	0.00192	CcSEcCtD
Fosphenytoin—Asthma—Methotrexate—muscle cancer	0.00118	0.00192	CcSEcCtD
Fosphenytoin—Affect lability—Doxorubicin—muscle cancer	0.00117	0.00189	CcSEcCtD
Fosphenytoin—Migraine—Doxorubicin—muscle cancer	0.00117	0.00189	CcSEcCtD
Fosphenytoin—Discomfort—Etoposide—muscle cancer	0.00116	0.00188	CcSEcCtD
Fosphenytoin—Face oedema—Doxorubicin—muscle cancer	0.00115	0.00186	CcSEcCtD
Fosphenytoin—Confusional state—Etoposide—muscle cancer	0.00113	0.00184	CcSEcCtD
Fosphenytoin—Cardiac arrest—Doxorubicin—muscle cancer	0.00113	0.00183	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Etoposide—muscle cancer	0.00112	0.00182	CcSEcCtD
Fosphenytoin—Mood swings—Doxorubicin—muscle cancer	0.00112	0.00182	CcSEcCtD
Fosphenytoin—Infection—Etoposide—muscle cancer	0.00112	0.00181	CcSEcCtD
Fosphenytoin—Ataxia—Doxorubicin—muscle cancer	0.00112	0.00181	CcSEcCtD
Fosphenytoin—Asthenia—Dactinomycin—muscle cancer	0.00111	0.00181	CcSEcCtD
Fosphenytoin—Dysuria—Methotrexate—muscle cancer	0.00111	0.00179	CcSEcCtD
Fosphenytoin—Dehydration—Doxorubicin—muscle cancer	0.0011	0.00179	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Etoposide—muscle cancer	0.0011	0.00178	CcSEcCtD
Fosphenytoin—Tachycardia—Etoposide—muscle cancer	0.0011	0.00178	CcSEcCtD
Fosphenytoin—Body temperature increased—Vincristine—muscle cancer	0.0011	0.00178	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Doxorubicin—muscle cancer	0.0011	0.00177	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Etoposide—muscle cancer	0.00109	0.00176	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00108	0.00176	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Methotrexate—muscle cancer	0.00108	0.00175	CcSEcCtD
Fosphenytoin—Hypokalaemia—Doxorubicin—muscle cancer	0.00108	0.00175	CcSEcCtD
Fosphenytoin—Anorexia—Etoposide—muscle cancer	0.00107	0.00174	CcSEcCtD
Fosphenytoin—Diarrhoea—Dactinomycin—muscle cancer	0.00106	0.00172	CcSEcCtD
Fosphenytoin—Pneumonia—Methotrexate—muscle cancer	0.00106	0.00172	CcSEcCtD
Fosphenytoin—Hypotension—Etoposide—muscle cancer	0.00105	0.0017	CcSEcCtD
Fosphenytoin—Gastritis—Doxorubicin—muscle cancer	0.00105	0.0017	CcSEcCtD
Fosphenytoin—Muscular weakness—Doxorubicin—muscle cancer	0.00105	0.0017	CcSEcCtD
Fosphenytoin—Renal failure—Methotrexate—muscle cancer	0.00104	0.00168	CcSEcCtD
Fosphenytoin—Conjunctivitis—Methotrexate—muscle cancer	0.00103	0.00166	CcSEcCtD
Fosphenytoin—Dysphagia—Doxorubicin—muscle cancer	0.00103	0.00166	CcSEcCtD
Fosphenytoin—Influenza—Doxorubicin—muscle cancer	0.00103	0.00166	CcSEcCtD
Fosphenytoin—Asthma—Doxorubicin—muscle cancer	0.00103	0.00166	CcSEcCtD
Fosphenytoin—Sweating—Methotrexate—muscle cancer	0.00101	0.00164	CcSEcCtD
Fosphenytoin—Paraesthesia—Etoposide—muscle cancer	0.00101	0.00164	CcSEcCtD
Fosphenytoin—Dyspnoea—Etoposide—muscle cancer	0.001	0.00162	CcSEcCtD
Fosphenytoin—Somnolence—Etoposide—muscle cancer	0.001	0.00162	CcSEcCtD
Fosphenytoin—Epistaxis—Methotrexate—muscle cancer	0.000996	0.00161	CcSEcCtD
Fosphenytoin—Asthenia—Vincristine—muscle cancer	0.000996	0.00161	CcSEcCtD
Fosphenytoin—Vomiting—Dactinomycin—muscle cancer	0.000988	0.0016	CcSEcCtD
Fosphenytoin—Bronchitis—Doxorubicin—muscle cancer	0.000986	0.0016	CcSEcCtD
Fosphenytoin—Rash—Dactinomycin—muscle cancer	0.00098	0.00159	CcSEcCtD
Fosphenytoin—Decreased appetite—Etoposide—muscle cancer	0.000978	0.00158	CcSEcCtD
Fosphenytoin—Constipation—Etoposide—muscle cancer	0.000962	0.00156	CcSEcCtD
Fosphenytoin—Dysuria—Doxorubicin—muscle cancer	0.000959	0.00155	CcSEcCtD
Fosphenytoin—Diarrhoea—Vincristine—muscle cancer	0.00095	0.00154	CcSEcCtD
Fosphenytoin—Pharyngitis—Methotrexate—muscle cancer	0.000941	0.00152	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000936	0.00152	CcSEcCtD
Fosphenytoin—Feeling abnormal—Etoposide—muscle cancer	0.000927	0.0015	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Doxorubicin—muscle cancer	0.000925	0.0015	CcSEcCtD
Fosphenytoin—Nausea—Dactinomycin—muscle cancer	0.000923	0.00149	CcSEcCtD
Fosphenytoin—Pneumonia—Doxorubicin—muscle cancer	0.00092	0.00149	CcSEcCtD
Fosphenytoin—Dizziness—Vincristine—muscle cancer	0.000918	0.00149	CcSEcCtD
Fosphenytoin—Renal failure—Doxorubicin—muscle cancer	0.000899	0.00146	CcSEcCtD
Fosphenytoin—Urticaria—Etoposide—muscle cancer	0.000893	0.00145	CcSEcCtD
Fosphenytoin—Body temperature increased—Etoposide—muscle cancer	0.000889	0.00144	CcSEcCtD
Fosphenytoin—Conjunctivitis—Doxorubicin—muscle cancer	0.000889	0.00144	CcSEcCtD
Fosphenytoin—Tinnitus—Methotrexate—muscle cancer	0.000884	0.00143	CcSEcCtD
Fosphenytoin—Vomiting—Vincristine—muscle cancer	0.000883	0.00143	CcSEcCtD
Fosphenytoin—Sweating—Doxorubicin—muscle cancer	0.000877	0.00142	CcSEcCtD
Fosphenytoin—Rash—Vincristine—muscle cancer	0.000875	0.00142	CcSEcCtD
Fosphenytoin—Dermatitis—Vincristine—muscle cancer	0.000874	0.00142	CcSEcCtD
Fosphenytoin—Headache—Vincristine—muscle cancer	0.00087	0.00141	CcSEcCtD
Fosphenytoin—Epistaxis—Doxorubicin—muscle cancer	0.000863	0.0014	CcSEcCtD
Fosphenytoin—Sinusitis—Doxorubicin—muscle cancer	0.000858	0.00139	CcSEcCtD
Fosphenytoin—Chills—Methotrexate—muscle cancer	0.000851	0.00138	CcSEcCtD
Fosphenytoin—Bradycardia—Doxorubicin—muscle cancer	0.000836	0.00135	CcSEcCtD
Fosphenytoin—Nausea—Vincristine—muscle cancer	0.000825	0.00134	CcSEcCtD
Fosphenytoin—Rhinitis—Doxorubicin—muscle cancer	0.000823	0.00133	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Doxorubicin—muscle cancer	0.000817	0.00132	CcSEcCtD
Fosphenytoin—Pharyngitis—Doxorubicin—muscle cancer	0.000815	0.00132	CcSEcCtD
Fosphenytoin—Dysgeusia—Methotrexate—muscle cancer	0.000808	0.00131	CcSEcCtD
Fosphenytoin—Asthenia—Etoposide—muscle cancer	0.000807	0.00131	CcSEcCtD
Fosphenytoin—Back pain—Methotrexate—muscle cancer	0.000798	0.00129	CcSEcCtD
Fosphenytoin—Pruritus—Etoposide—muscle cancer	0.000796	0.00129	CcSEcCtD
Fosphenytoin—Diarrhoea—Etoposide—muscle cancer	0.000769	0.00125	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methotrexate—muscle cancer	0.000766	0.00124	CcSEcCtD
Fosphenytoin—Tinnitus—Doxorubicin—muscle cancer	0.000765	0.00124	CcSEcCtD
Fosphenytoin—Anaemia—Methotrexate—muscle cancer	0.000763	0.00124	CcSEcCtD
Fosphenytoin—Malaise—Methotrexate—muscle cancer	0.000744	0.00121	CcSEcCtD
Fosphenytoin—Dizziness—Etoposide—muscle cancer	0.000744	0.0012	CcSEcCtD
Fosphenytoin—Vertigo—Methotrexate—muscle cancer	0.000742	0.0012	CcSEcCtD
Fosphenytoin—Leukopenia—Methotrexate—muscle cancer	0.000739	0.0012	CcSEcCtD
Fosphenytoin—Chills—Doxorubicin—muscle cancer	0.000737	0.00119	CcSEcCtD
Fosphenytoin—Cough—Methotrexate—muscle cancer	0.00072	0.00117	CcSEcCtD
Fosphenytoin—Convulsion—Methotrexate—muscle cancer	0.000715	0.00116	CcSEcCtD
Fosphenytoin—Vomiting—Etoposide—muscle cancer	0.000715	0.00116	CcSEcCtD
Fosphenytoin—Rash—Etoposide—muscle cancer	0.000709	0.00115	CcSEcCtD
Fosphenytoin—Dermatitis—Etoposide—muscle cancer	0.000708	0.00115	CcSEcCtD
Fosphenytoin—Headache—Etoposide—muscle cancer	0.000704	0.00114	CcSEcCtD
Fosphenytoin—Flatulence—Doxorubicin—muscle cancer	0.000704	0.00114	CcSEcCtD
Fosphenytoin—Myalgia—Methotrexate—muscle cancer	0.000703	0.00114	CcSEcCtD
Fosphenytoin—Arthralgia—Methotrexate—muscle cancer	0.000703	0.00114	CcSEcCtD
Fosphenytoin—Tension—Doxorubicin—muscle cancer	0.000701	0.00114	CcSEcCtD
Fosphenytoin—Dysgeusia—Doxorubicin—muscle cancer	0.0007	0.00113	CcSEcCtD
Fosphenytoin—Discomfort—Methotrexate—muscle cancer	0.000694	0.00112	CcSEcCtD
Fosphenytoin—Nervousness—Doxorubicin—muscle cancer	0.000694	0.00112	CcSEcCtD
Fosphenytoin—Back pain—Doxorubicin—muscle cancer	0.000691	0.00112	CcSEcCtD
Fosphenytoin—Muscle spasms—Doxorubicin—muscle cancer	0.000687	0.00111	CcSEcCtD
Fosphenytoin—Confusional state—Methotrexate—muscle cancer	0.000679	0.0011	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methotrexate—muscle cancer	0.000674	0.00109	CcSEcCtD
Fosphenytoin—Infection—Methotrexate—muscle cancer	0.000669	0.00108	CcSEcCtD
Fosphenytoin—Nausea—Etoposide—muscle cancer	0.000668	0.00108	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Doxorubicin—muscle cancer	0.000663	0.00107	CcSEcCtD
Fosphenytoin—Anaemia—Doxorubicin—muscle cancer	0.000661	0.00107	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Methotrexate—muscle cancer	0.00066	0.00107	CcSEcCtD
Fosphenytoin—Agitation—Doxorubicin—muscle cancer	0.000657	0.00106	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methotrexate—muscle cancer	0.000651	0.00105	CcSEcCtD
Fosphenytoin—Malaise—Doxorubicin—muscle cancer	0.000644	0.00104	CcSEcCtD
Fosphenytoin—Vertigo—Doxorubicin—muscle cancer	0.000642	0.00104	CcSEcCtD
Fosphenytoin—Anorexia—Methotrexate—muscle cancer	0.000642	0.00104	CcSEcCtD
Fosphenytoin—Syncope—Doxorubicin—muscle cancer	0.000641	0.00104	CcSEcCtD
Fosphenytoin—Leukopenia—Doxorubicin—muscle cancer	0.00064	0.00104	CcSEcCtD
Fosphenytoin—Palpitations—Doxorubicin—muscle cancer	0.000632	0.00102	CcSEcCtD
Fosphenytoin—Hypotension—Methotrexate—muscle cancer	0.000629	0.00102	CcSEcCtD
Fosphenytoin—Loss of consciousness—Doxorubicin—muscle cancer	0.000628	0.00102	CcSEcCtD
Fosphenytoin—Cough—Doxorubicin—muscle cancer	0.000624	0.00101	CcSEcCtD
Fosphenytoin—Convulsion—Doxorubicin—muscle cancer	0.000619	0.001	CcSEcCtD
Fosphenytoin—Hypertension—Doxorubicin—muscle cancer	0.000617	0.000999	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000614	0.000994	CcSEcCtD
Fosphenytoin—Insomnia—Methotrexate—muscle cancer	0.000609	0.000987	CcSEcCtD
Fosphenytoin—Arthralgia—Doxorubicin—muscle cancer	0.000608	0.000985	CcSEcCtD
Fosphenytoin—Myalgia—Doxorubicin—muscle cancer	0.000608	0.000985	CcSEcCtD
Fosphenytoin—Paraesthesia—Methotrexate—muscle cancer	0.000605	0.00098	CcSEcCtD
Fosphenytoin—Discomfort—Doxorubicin—muscle cancer	0.000601	0.000974	CcSEcCtD
Fosphenytoin—Dyspnoea—Methotrexate—muscle cancer	0.000601	0.000973	CcSEcCtD
Fosphenytoin—Somnolence—Methotrexate—muscle cancer	0.000599	0.00097	CcSEcCtD
Fosphenytoin—Dry mouth—Doxorubicin—muscle cancer	0.000595	0.000964	CcSEcCtD
Fosphenytoin—Dyspepsia—Methotrexate—muscle cancer	0.000593	0.00096	CcSEcCtD
Fosphenytoin—Confusional state—Doxorubicin—muscle cancer	0.000588	0.000953	CcSEcCtD
Fosphenytoin—Decreased appetite—Methotrexate—muscle cancer	0.000586	0.000948	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Doxorubicin—muscle cancer	0.000583	0.000945	CcSEcCtD
Fosphenytoin—Infection—Doxorubicin—muscle cancer	0.000579	0.000939	CcSEcCtD
Fosphenytoin—Shock—Doxorubicin—muscle cancer	0.000574	0.000929	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Doxorubicin—muscle cancer	0.000571	0.000925	CcSEcCtD
Fosphenytoin—Tachycardia—Doxorubicin—muscle cancer	0.000569	0.000922	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Doxorubicin—muscle cancer	0.000564	0.000913	CcSEcCtD
Fosphenytoin—Anorexia—Doxorubicin—muscle cancer	0.000556	0.000901	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methotrexate—muscle cancer	0.000555	0.000899	CcSEcCtD
Fosphenytoin—Hypotension—Doxorubicin—muscle cancer	0.000545	0.000883	CcSEcCtD
Fosphenytoin—Urticaria—Methotrexate—muscle cancer	0.000535	0.000867	CcSEcCtD
Fosphenytoin—Body temperature increased—Methotrexate—muscle cancer	0.000532	0.000862	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000531	0.000861	CcSEcCtD
Fosphenytoin—Insomnia—Doxorubicin—muscle cancer	0.000528	0.000854	CcSEcCtD
Fosphenytoin—Paraesthesia—Doxorubicin—muscle cancer	0.000524	0.000848	CcSEcCtD
Fosphenytoin—Dyspnoea—Doxorubicin—muscle cancer	0.00052	0.000842	CcSEcCtD
Fosphenytoin—Somnolence—Doxorubicin—muscle cancer	0.000519	0.00084	CcSEcCtD
Fosphenytoin—Dyspepsia—Doxorubicin—muscle cancer	0.000513	0.000832	CcSEcCtD
Fosphenytoin—Decreased appetite—Doxorubicin—muscle cancer	0.000507	0.000821	CcSEcCtD
Fosphenytoin—Constipation—Doxorubicin—muscle cancer	0.000499	0.000808	CcSEcCtD
Fosphenytoin—Asthenia—Methotrexate—muscle cancer	0.000483	0.000783	CcSEcCtD
Fosphenytoin—Feeling abnormal—Doxorubicin—muscle cancer	0.000481	0.000778	CcSEcCtD
Fosphenytoin—Pruritus—Methotrexate—muscle cancer	0.000477	0.000772	CcSEcCtD
Fosphenytoin—Urticaria—Doxorubicin—muscle cancer	0.000463	0.000751	CcSEcCtD
Fosphenytoin—Body temperature increased—Doxorubicin—muscle cancer	0.000461	0.000747	CcSEcCtD
Fosphenytoin—Diarrhoea—Methotrexate—muscle cancer	0.000461	0.000746	CcSEcCtD
Fosphenytoin—Dizziness—Methotrexate—muscle cancer	0.000445	0.000721	CcSEcCtD
Fosphenytoin—Vomiting—Methotrexate—muscle cancer	0.000428	0.000694	CcSEcCtD
Fosphenytoin—Rash—Methotrexate—muscle cancer	0.000425	0.000688	CcSEcCtD
Fosphenytoin—Dermatitis—Methotrexate—muscle cancer	0.000424	0.000687	CcSEcCtD
Fosphenytoin—Headache—Methotrexate—muscle cancer	0.000422	0.000683	CcSEcCtD
Fosphenytoin—Asthenia—Doxorubicin—muscle cancer	0.000418	0.000678	CcSEcCtD
Fosphenytoin—Pruritus—Doxorubicin—muscle cancer	0.000413	0.000668	CcSEcCtD
Fosphenytoin—Nausea—Methotrexate—muscle cancer	0.0004	0.000648	CcSEcCtD
Fosphenytoin—Diarrhoea—Doxorubicin—muscle cancer	0.000399	0.000646	CcSEcCtD
Fosphenytoin—Dizziness—Doxorubicin—muscle cancer	0.000386	0.000625	CcSEcCtD
Fosphenytoin—Vomiting—Doxorubicin—muscle cancer	0.000371	0.000601	CcSEcCtD
Fosphenytoin—Rash—Doxorubicin—muscle cancer	0.000368	0.000596	CcSEcCtD
Fosphenytoin—Dermatitis—Doxorubicin—muscle cancer	0.000367	0.000595	CcSEcCtD
Fosphenytoin—Headache—Doxorubicin—muscle cancer	0.000365	0.000592	CcSEcCtD
Fosphenytoin—Nausea—Doxorubicin—muscle cancer	0.000346	0.000561	CcSEcCtD
